Real-life analysis of pathologic complete response with neoadjuvant trastuzumab plus taxane with or without pertuzumab therapy in HER2 positive locally-advanced breast cancer (HER2PATH Study).

dc.contributor.authorBilici, Ahmet
dc.contributor.authorOlmez, Omer Fatih
dc.contributor.authorSezer, Ahmet
dc.contributor.authorOksuzoglu, Berna
dc.contributor.authorKaplan, Muhammet Ali
dc.contributor.authorKaradurmus, Nuri
dc.contributor.authorCubukcu, Erdem
dc.contributor.authorSendur, Mehmet A. N.
dc.contributor.authorAksoy, Sercan
dc.contributor.authorErdem, Dilek
dc.contributor.authorBasaran, Gul
dc.contributor.authorCakar, Burcu
dc.contributor.authorSeker, Mesut
dc.contributor.authorArslan, Cagatay
dc.contributor.authorGoksu, Sema Sezgin
dc.contributor.authorCicin, Irfan
dc.contributor.authorGumus, Mahmut
dc.contributor.authorSelcukbiricik, Fatih
dc.contributor.authorHarputluoglu, Hakan
dc.contributor.authorHelvaci, Kaan
dc.date.accessioned2022-11-04T10:21:18Z
dc.date.available2022-11-04T10:21:18Z
dc.date.issued2022
dc.identifier.issn0732-183Xen_US
dc.identifier.issue16en_US
dc.identifier.urihttp://hdl.handle.net/11727/8006
dc.identifier.volume40en_US
dc.identifier.wos000863680302513en_US
dc.language.isoengen_US
dc.relation.journalJOURNAL OF CLINICAL ONCOLOGYen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleReal-life analysis of pathologic complete response with neoadjuvant trastuzumab plus taxane with or without pertuzumab therapy in HER2 positive locally-advanced breast cancer (HER2PATH Study).en_US
dc.typeconferenceObjecten_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: